Comparing Moderna's mRNA-1083 and Pfizer's dual-target mRNA vaccines for influenza and COVID-19

Adewunmi Akingbola1, Abiodun Adegbesan2, Kolade Adegoke3

  • 1Department of Public Health and Primary Care, University of Cambridge Old Schools Trinity Lane CB2 1TN Cambridgeshire England, Cambridge, UK.

NPJ Vaccines
|May 24, 2025
PubMed